BACKGROUND: Adverse viral and medication effects on adipose tissue contribute to the development of metabolic disease in HIV-infected persons, but T cells also have a central role modulating local inflammation and adipocyte function. We sought to characterize potentially proinflammatory T-cell populations in adipose tissue among persons on long-term antiretroviral therapy and assess whether adipose tissue CD8 T cells represent an expanded, oligoclonal population. METHODS: We recruited 10 HIV-infected, non-diabetic, overweight or obese adults on efavirenz, tenofovir, and emtricitabine for >4 years with consistent viral suppression. We collected fasting blood and subcutaneous abdominal adipose tissue to measure the percentage of CD4 and CD8 T cells expressing activation, exhaustion, late differentiation/senescence, and memory surface markers. We performed T-cell receptor (TCR) sequencing on sorted CD8 cells. We compared the proportion of each T-cell subset and the TCR repertoire diversity, in blood versus adipose tissue. RESULTS: Adipose tissue had a higher percentage of CD3CD8 T cells compared with blood (61.0% vs. 51.7%, P < 0.01) and was enriched for both activated CD8HLA-DR T cells (5.5% vs. 0.9%, P < 0.01) and late-differentiated CD8CD57 T cells (37.4% vs. 22.7%, P < 0.01). Adipose tissue CD8 T cells displayed distinct TCRβ V and J gene usage, and the Shannon Entropy index, a measure of overall TCRβ repertoire diversity, was lower compared with blood (4.39 vs. 4.46; P = 0.05). CONCLUSIONS: Adipose tissue is enriched for activated and late-differentiated CD8 T cells with distinct TCR usage. These cells may contribute to tissue inflammation and impaired adipocyte fitness in HIV-infected persons.
BACKGROUND: Adverse viral and medication effects on adipose tissue contribute to the development of metabolic disease in HIV-infected persons, but T cells also have a central role modulating local inflammation and adipocyte function. We sought to characterize potentially proinflammatory T-cell populations in adipose tissue among persons on long-term antiretroviral therapy and assess whether adipose tissue CD8 T cells represent an expanded, oligoclonal population. METHODS: We recruited 10 HIV-infected, non-diabetic, overweight or obese adults on efavirenz, tenofovir, and emtricitabine for >4 years with consistent viral suppression. We collected fasting blood and subcutaneous abdominal adipose tissue to measure the percentage of CD4 and CD8 T cells expressing activation, exhaustion, late differentiation/senescence, and memory surface markers. We performed T-cell receptor (TCR) sequencing on sorted CD8 cells. We compared the proportion of each T-cell subset and the TCR repertoire diversity, in blood versus adipose tissue. RESULTS: Adipose tissue had a higher percentage of CD3CD8 T cells compared with blood (61.0% vs. 51.7%, P < 0.01) and was enriched for both activated CD8HLA-DR T cells (5.5% vs. 0.9%, P < 0.01) and late-differentiated CD8CD57 T cells (37.4% vs. 22.7%, P < 0.01). Adipose tissue CD8 T cells displayed distinct TCRβ V and J gene usage, and the Shannon Entropy index, a measure of overall TCRβ repertoire diversity, was lower compared with blood (4.39 vs. 4.46; P = 0.05). CONCLUSIONS: Adipose tissue is enriched for activated and late-differentiated CD8 T cells with distinct TCR usage. These cells may contribute to tissue inflammation and impaired adipocyte fitness in HIV-infected persons.
Authors: Simon P Jones; Nadeem Qazi; John Morelese; Dirk Lebrecht; Jussi Sutinen; Hannele Yki-Jărvinen; David J Back; Munir Pirmohamed; Brian G Gazzard; Ulrich A Walker; Graeme J Moyle Journal: J Acquir Immune Defic Syndr Date: 2005-12-15 Impact factor: 3.731
Authors: Cecilia M Shikuma; Louie Mar A Gangcuangco; Deirdre A Killebrew; Daniel E Libutti; Dominic C Chow; Beau K Nakamoto; Chin Yuan Liang; Cris I P Milne; Lishomwa C Ndhlovu; Jason D Barbour; Bruce T Shiramizu; Mariana Gerschenson Journal: J Acquir Immune Defic Syndr Date: 2014-02-01 Impact factor: 3.731
Authors: Brent E Palmer; Douglas G Mack; Allison K Martin; Lisa A Maier; Andrew P Fontenot Journal: J Allergy Clin Immunol Date: 2007-04-09 Impact factor: 10.793
Authors: John R Koethe; Cathy A Jenkins; Christopher Petucci; Jeffrey Culver; Bryan E Shepherd; Timothy R Sterling Journal: Medicine (Baltimore) Date: 2016-05 Impact factor: 1.889
Authors: Wyatt J McDonnell; John R Koethe; Simon A Mallal; Mark A Pilkinton; Annet Kirabo; Magdalene K Ameka; Matthew A Cottam; Alyssa H Hasty; Arion J Kennedy Journal: Diabetes Date: 2018-09-04 Impact factor: 9.461
Authors: Celestine N Wanjalla; Mona Mashayekhi; Samuel Bailin; Curtis L Gabriel; Leslie M Meenderink; Tecla Temu; Daniella T Fuller; Liang Guo; Kenji Kawai; Renu Virmani; Cathy Jenkins; Chike O Abana; Christian M Warren; Rama Gangula; Rita Smith; Meena S Madhur; Aloke V Finn; Alexander H Gelbard; Yan Ru Su; Matthew J Tyska; Spyros A Kalams; David G Harrison; Simon A Mallal; Tarek S Absi; Joshua A Beckman; John R Koethe Journal: Arterioscler Thromb Vasc Biol Date: 2021-02-11 Impact factor: 8.311
Authors: W M Han; A Jiamsakul; J Jantarapakde; E Yunihastuti; J Y Choi; R Ditangco; R Chaiwarith; L P Sun; S Khusuwan; T P Merati; C D Do; I Azwa; M-P Lee; K Van Nguyen; Y-J Chan; S Kiertiburanakul; O T Ng; J Tanuma; S Pujari; F Zhang; Y M Gani; S Sangle; J Ross; N Kumarasamy Journal: HIV Med Date: 2020-11-17 Impact factor: 3.180